Conjugation effects of various linkers on Gd(III) MRI contrast agents with dendrimers: optimizing the hydroxypyridinonate (HOPO) ligands with nontoxic, degradable esteramide (EA) dendrimers for high relaxivity

Conjugation effects of various linkers on Gd(III) MRI contrast agents with dendrimers: optimizing the hydroxypyridinonate (HOPO) ligands with nontoxic, degradable esteramide (EA) dendrimers for high relaxivity

Item

http://www.wikidata.org/entity/Q24594049

Q24594049

about

Lanthanide probes for bioresponsive imaging Porphyrin-Substituted H-NOX Proteins as High-Relaxivity MRI Contrast Agents Organic radical contrast agents for magnetic resonance imaging.Discrete nanomolecular polyhedral borane scaffold supporting multiple gadolinium(III) complexes as a high performance MRI contrast agent De novo design of Ln(III) coiled coils for imaging applications.Metal Chelating Crosslinkers Form Nanogels with High Chelation Stability.Fabrication and Characterization of Gd-DTPA-Loaded Chitosan-Poly(Acrylic Acid) Nanoparticles for Magnetic Resonance Imaging.Near-infrared light-triggered theranostics for tumor-specific enhanced multimodal imaging and photothermal therapy Analytical methods for characterizing magnetic resonance probes.Structurally Diverse Nitric Oxide-Releasing Poly(propylene Imine) Dendrimers.Eu(II)-containing cryptates as contrast agents for ultra-high field strength magnetic resonance imaging.Silica microparticles as a solid support for gadolinium phosphonate magnetic resonance imaging contrast agents.Analysis of Lanthanide Complex Dendrimer Conjugates for Bimodal NIR and MRI Imaging.cRGD peptide-conjugated icosahedral closo-B12(2-) core carrying multiple Gd3+-DOTA chelates for α(v)β3 integrin-targeted tumor imaging (MRI).Conjugation to Biocompatible Dendrimers Increases Lanthanide T2 Relaxivity of Hydroxypyridinone (HOPO) Complexes for Magnetic Resonance Imaging (MRI)Metal-containing and related polymers for biomedical applications.Catechol-based biomimetic functional materials.Magnetic resonance imaging (MRI) contrast agents for tumor diagnosis.Engineering Gd-loaded nanoparticles to enhance MRI sensitivity via T(1) shortening.Advanced Functional Nanomaterials for Theranostics.Tobacco mosaic virus rods and spheres as supramolecular high-relaxivity MRI contrast agents New luminescent oxygen-sensing and temperature-sensing materials based on gadolinium(III) and europium(III) complexes embedded in an acridone-polystyrene conjugate.Exceptional Oxygen Sensing Properties of New Blue Light-Excitable Highly Luminescent Europium(III) and Gadolinium(III) Complexes Synthesis and chemical reactivity of a 6-Me-3,2-hydroxypyridinone dithiazolide with primary amines: a route to new hexadentate chelators for hard metal(III) ions.3,2-Hydroxypyridinone (3,2-HOPO) vinyl sulfonamide and acrylamide linkers: Aza-Michael addition reactions and the preparation of poly-HOPO chelators.MRI-guided targeting delivery of doxorubicin with reduction-responsive lipid-polymer hybrid nanoparticles.Synthesis and relaxivity studies of a DOTA-based nanomolecular chelator assembly supported by an icosahedral closo-B₁₂²⁻ core for MRI: a click chemistry approach.Paramagnetic self-assembled nanoparticles as supramolecular MRI contrast agents.Electrospun Contrast-Agent-Loaded Fibers for Colon-Targeted MRI.Stealth rare earth oxide nanodiscs for magnetic resonance imaging.Surface impact on nanoparticle-based magnetic resonance imaging contrast agents.Synthesis and Characterization of Ligands and their Gadolinium(III) Complexes Anti-Biofouling Polymer-Decorated Lutetium-Based Nanoparticulate Contrast Agents for In Vivo High-Resolution Trimodal Imaging Structure, Dynamics, and Computational Studies of Lanthanide-Based Contrast Agents

P2860

Q27000361-694B728C-DE3F-4A81-AC34-4BB2624A10F3 Q27676243-EB913B48-7107-4943-AB17-50157EB0C4FB Q30565003-827E6F2E-EAF5-4234-93EC-09D5FC7FB36A Q30576125-EE507582-D0A3-4EE6-A793-412A667B1A55 Q30729722-EEF59BD8-B2F2-4A34-961B-866B3912A1C1 Q30751363-36C4EF7E-C119-405B-B531-F4E6F2ABC204 Q30924405-72145408-0DC3-4E64-9643-27FCDF9505A7 Q33825897-26E4E279-B81F-4AE4-A797-0B69B670011B Q34280357-93117223-F1EE-4426-8E52-B554FD0F31A0 Q35485272-3D358726-60E8-43AF-B29A-C6660B6038FD Q35665118-97B772A4-F469-45F1-BCE7-CEDCC8D7D5A9 Q36112041-D6F3F8E8-0305-4068-9FF1-978E337AF4D3 Q36443368-A6C14167-04AA-47E7-91EF-95E7F4860373 Q36671358-B2FBDAF4-527A-4D0A-AF4B-B20D83A7D7D4 Q36714422-BA463991-B240-4137-A400-34CE5E37FC79 Q37201391-076291A5-ABDD-42F2-BB7E-EDA0F68DF56E Q38062517-E02D2538-7BD3-489D-B7CA-3F95C30C0332 Q38090392-B5BAEFE4-B082-48C1-822B-71200F1C9B03 Q38155457-588A8990-4DA5-46BD-BD13-1655509F2456 Q38639877-6C50E26F-1023-4D40-B2F2-CBF1F5B052CE Q39804161-1365EEEF-7BA1-4819-BECD-5735F6061E65 Q40049994-ACD7BAA1-A80A-489F-8D71-445F73A6142B Q40938419-B702E443-FD71-44F7-B564-17E4DA63EE24 Q41130080-88EC37C3-7D85-430E-A612-620D24897417 Q41950065-0E42F1BF-5EDE-46BA-AC68-AFE89289F427 Q42736005-073C7D5E-39BB-45C0-8770-59E97170C30A Q45814502-87C9305D-1BE9-4475-AD13-727915115B57 Q48545737-3023FBB0-486F-4066-819B-B18DC9CECA66 Q51505968-73E1B47A-DCE2-4481-9209-ABEA87DBB55E Q53131221-D8FF8296-B755-41AF-956B-60A6A4678D52 Q55073008-894E3B8A-396F-4F86-ADFF-842A345CD5F4 Q57340454-5F93A840-8C29-4D4C-85E3-7BDC3EED863A Q57345583-87D0D148-5B2A-4082-A070-57EC74E56F5C Q57391311-DE73A7B4-E94E-4F39-9DC2-CD80FFAC06D8

P2860

Conjugation effects of various linkers on Gd(III) MRI contrast agents with dendrimers: optimizing the hydroxypyridinonate (HOPO) ligands with nontoxic, degradable esteramide (EA) dendrimers for high relaxivity

Item

http://www.wikidata.org/entity/Q24594049

description

2011 nî lūn-bûn

@nan

2011 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի մարտին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu